Results 161 to 170 of about 29,812 (199)
Some of the next articles are maybe not open access.
Telestroke: Variations in Intravenous Thrombolysis by Spoke Hospitals
Journal of Stroke and Cerebrovascular Diseases, 2015Telestroke extends stroke expertise to underserved hospitals and facilitates treatment with tissue plasminogen activator (tPA). We investigated the variability in tPA treatment rates across 2 large telestroke networks-consisting of hubs at Georgia Regents Medical Center (GRMC) and Medical University of South Carolina (MUSC) and their affiliated spoke ...
Jeffrey A. Switzer +5 more
openaire +2 more sources
Intravenous Thrombolysis for Acute Ischemic Stroke
Journal of Vascular and Interventional Radiology, 2004Intravenous recombinant tissue-type plasminogen activator (rtPA, alteplase) is the only drug approved for the treatment of acute ischemic stroke. It should be administered within 3 hours of stroke. There is additional evidence, however, that administration at later times, by means of other methods, is effective.
openaire +2 more sources
Successful Intravenous Thrombolysis in a Stroke Patient With Hemiballism
The Neurologist, 2011Hemiballism (HB) is a relatively rare hyperkinetic disorder commonly caused by an acute stroke. Such patients usually receive symptomatic therapy with limited effect. We report the case of an acute stroke patient with HB who was successfully treated with intravenous recombinant tissue plasminogen activator (rtPA).A 67-year-old man with a history of ...
Jasna, Zidverc-Trajković +4 more
openaire +2 more sources
Intravenous Thrombolysis and Anti-thrombotics
2016Intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) has revolutionized acute ischemic stroke care in the last two decades. The NINDS stroke study was pivotal in this transformation and conclusively demonstrated meaningful clinical improvement when IV rtPA is administered in the first 3 h of symptom onset.
Mahesh P. Kate +2 more
openaire +1 more source
[Comparison of intravenous thrombolysis and intracoronary thrombolysis].
Presse medicale (Paris, France : 1983), 1988Any comparison between intravenous and intracoronary thrombolysis must take into account such elements as the delays imposed by coronary arteriography, the extra cost of the procedure, etc., but ultimately the answer can only be provided by a controlled trial comparing the two approaches.
openaire +1 more source
Advantages and limits of intravenous thrombolysis
Journal of Molecular and Cellular Cardiology, 1988A M, De Biase, F, Mauri, F, Rovelli
openaire +2 more sources